glucose, (beta-d)-isomer has been researched along with Neutropenia in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (30.43) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (17.39) | 2.80 |
| Authors | Studies |
|---|---|
| Brammsen, H; Hofstaetter, T | 1 |
| Carter, GW; Gilbertsen, RB; Quinn, DJ | 1 |
| Andres, DW; Doerschuk, CM; Doyle, NA; Kutkoski, GJ; Quinlan, WM | 1 |
| Bautista, AP; Jaeschke, H; Smith, CW; Spitzer, JJ; Spolarics, Z | 1 |
| Boerman, OC; Corstens, FH; Laverman, P; Oyen, WJ; van de Ven, MT; van der Laken, CJ; van der Meer, JW | 1 |
| Fehr, J; Jacob, HS | 1 |
| Doerschuk, CM; English, D; Inano, H | 1 |
| Bautista, AP; Schuler, A; Spitzer, JJ; Spolarics, Z | 1 |
| Elsner, J; Emmendörffer, A; Lohmann-Matthes, M; Roesler, J; Welte, K; Zeidler, C | 1 |
| McDonald, JW; Smallbone, BW; Taylor, NE | 1 |
| Mata, R; Muniain, MA; Pérez, JJ; Pozuelo, F; Rodríguez, MC; Rodríguez, MD; Romero, A | 1 |
| Leirisalo-Repo, M; Repo, H; Savilahti, E | 1 |
| Davies, BJ; McDonald, JW; Noulty, EJ; Pisters, LL; Smallbone, BW; Taylor, NE | 1 |
| Adrian, K; Al-Thihli, K; Ballhausen, D; Bidiuk, J; Bordugo, A; Boyer, M; Bratkovic, D; Brunner-Krainz, M; Burlina, A; Chakrapani, A; Corpeleijn, W; Cozens, A; Dawson, C; Derks, TGJ; Dhamko, H; Eiroa, H; Finezilber, Y; Fraile, PQ; Fung, LH; Garcia-Jiménez, MC; Gasperini, S; Grünert, SC; Haas, D; Häberle, J; Halligan, R; Hörbe-Blindt, A; Horka, LM; Huemer, M; Kecman, B; Kilavuz, S; Kriván, G; Lindner, M; Lüsebrink, N; Maier, EM; Maiorana, A; Makrilakis, K; McCandless, SE; Mei-Kwun Kwok, A; Milosevic, MD; Mitchell, JJ; Mizumoto, H; Moura de Souza, CF; Mundy, H; Ochoa, C; Pierce, K; Regier, D; Rossi, A; Santer, R; Schrier Vergano, SA; Schuman, HC; Sobieraj, P; Spenger, J; Spiegel, R; Stepien, KM; Tal, G; Tanšek, MZ; Tchan, M; Thyagu, S; Torkar, AD; Uçar, SK; Vucko, E; Weinhold, N; Wortmann, SB; Zsidegh, P | 1 |
| Boulanger, C; Chevalier, N; Diederich, J; Ferster, A; Mounkoro, P; Stephenne, X; Van Schaftingen, E; Veiga-da-Cunha, M | 1 |
| Chevalier, N; Derks, TGJ; Gaughan, S; Knight, V; Koller, A; Lagler, FB; Mayr, JA; Oussoren, E; Van Hove, JLK; Van Schaftingen, E; van Spronsen, FJ; Veiga-da-Cunha, M; Wortmann, SB | 1 |
| Arai, A; Mikami, M; Mizumoto, H | 1 |
| Brell, J; Chak, A; Dowlati, A; Fu, P; Hoppel, CL; Ingalls, S; Ivy, P; Krishnamurthi, S; Posey, J; Ramanathan, RK; Rath, L; Remick, SC | 1 |
| Alberti, D; Arzoomanian, R; Binger, K; Cleary, J; Dresen, A; Feierabend, C; Marnoccha, R; Merchant, J; Thomas, J; Tutsch, K; Wilding, G | 1 |
| Baruchel, S; Bernstein, M; Blaney, S; Furman, W; Kuhn, JG; Langevin, AM; Vietti, T; Weintraub, ST; Weitman, SD | 1 |
| Berg, K; Forero, L; Forouzesh, B; Goetz, A; Hammond, LA; Kuhn, JG; Ochoa-Bayona, JL; Ricart, AD; Rowinsky, EK; Takimoto, CH; Tolcher, AW | 1 |
| Dowlati, A; Gerson, SL; Hoppel, CL; Ingalls, ST; Ivy, P; Li, X; Majka, S; Remick, SC; Sedransk, N; Spiro, T | 1 |
| Aylesworth, C; Campbell, E; Eckhardt, SG; Felton, S; Hammond, L; Hidalgo, M; Kuhn, J; Patnaik, A; Rizzo, J; Rowinsky, EK; Schwartz, G; Tolcher, AW; Weiss, G | 1 |
6 trial(s) available for glucose, (beta-d)-isomer and Neutropenia
| Article | Year |
|---|---|
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
Topics: Aged; Antineoplastic Agents; Bile Duct Neoplasms; CA-19-9 Antigen; Carbazoles; Female; Fever; Gallbladder Neoplasms; Glucosides; Humans; Male; Middle Aged; Neutropenia; Survival Rate; Thrombocytopenia | 2009 |
Phase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Glucosides; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia | 2002 |
Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Area Under Curve; Carbazoles; Child; Child, Preschool; Drug Administration Schedule; Glucosides; Hemoglobins; Humans; Infant; Metabolic Clearance Rate; Neoplasms; Neutropenia; Patient Selection; Platelet Count | 2003 |
Phase I and pharmacokinetic study of sequences of the rebeccamycin analogue NSC 655649 and cisplatin in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Cisplatin; Drug Interactions; Female; Glucosides; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia; Tomography, X-Ray Computed | 2005 |
Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Cholangiocarcinoma; Disease Progression; Dose-Response Relationship, Drug; Female; Gallbladder Neoplasms; Glucosides; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia | 2001 |
Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Dose-Response Relationship, Drug; Female; Glucosides; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia | 2001 |
17 other study(ies) available for glucose, (beta-d)-isomer and Neutropenia
| Article | Year |
|---|---|
A microassay for nitroblue tetrazolium reduction by human neutrophils.
Topics: Dose-Response Relationship, Drug; Egtazic Acid; Humans; Immunologic Techniques; Magnesium; Neutropenia; Neutrophils; Nitroblue Tetrazolium; Tetrazolium Salts; Zymosan | 1981 |
Effects of F-met-leu-phe and zymosan-activated serum on rat neutrophils in vivo.
Topics: Agranulocytosis; Animals; Chemotactic Factors; Dose-Response Relationship, Drug; Kinetics; Leukocyte Count; Leukocytosis; Male; Monocytes; Neutropenia; Neutrophils; Oligopeptides; Rats; Zymosan | 1980 |
Effect of pentoxifylline on changes in neutrophil sequestration and emigration in the lungs.
Topics: Animals; Blood Cell Count; Cell Movement; Leukocyte Count; Lung; Neutropenia; Neutrophils; Pentoxifylline; Plasma; Pneumonia, Staphylococcal; Rabbits; Zymosan | 1995 |
Antineutrophil monoclonal antibody (1F12) alters superoxide anion release by neutrophils and Kupffer cells.
Topics: Animals; Antibodies, Monoclonal; Blood Cell Count; Cell Death; Flow Cytometry; Fluorescein-5-isothiocyanate; Free Radicals; Kupffer Cells; Liver; Male; Neutropenia; Neutrophils; Oxygen; Rats; Rats, Sprague-Dawley; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1994 |
In vivo expression of interleukin-1 receptors during various experimentally induced inflammatory conditions.
Topics: Animals; Candida albicans; Candidiasis; Escherichia coli Infections; Humans; Inflammation; Interleukin-1; Mice; Neutropenia; Polymerase Chain Reaction; Receptors, Interleukin-1; Recombinant Proteins; RNA, Messenger; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution; Transcription, Genetic; Turpentine; Zymosan | 1998 |
In vitro granulocyte adherence and in vivo margination: two associated complement-dependent functions. Studies based on the acute neutropenia of filtration leukophoresis.
Topics: Agranulocytosis; Animals; Cell Adhesion; Complement C3; Complement System Proteins; Granulocytes; Hot Temperature; Humans; Hydrazines; Inulin; Leukocytes; Neutropenia; Rabbits; Zymosan | 1977 |
Effect of zymosan-activated plasma on the deformability of rabbit polymorphonuclear leukocytes.
Topics: Actins; Animals; Colchicine; Complement System Proteins; Cytochalasin B; Cytoskeleton; Filtration; In Vitro Techniques; Microtubules; Neutropenia; Neutrophils; Peptide Fragments; Rabbits; Zymosan | 1992 |
Tumor necrosis factor-alpha stimulates superoxide anion generation by perfused rat liver and Kupffer cells.
Topics: Animals; Cell Movement; Cytochrome c Group; Humans; Kinetics; Kupffer Cells; Liver; Male; Neutropenia; Neutrophils; Perfusion; Rats; Rats, Inbred Strains; Superoxides; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Zymosan | 1991 |
In vitro functions of neutrophils induced by treatment with rhG-CSF in severe congenital neutropenia.
Topics: Blood Bactericidal Activity; Cell Nucleus; Chemotaxis, Leukocyte; Cytoplasm; Eosinophils; Free Radicals; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; N-Formylmethionine Leucyl-Phenylalanine; Neutropenia; Neutrophils; Oxygen; Phagocytes; Phagocytosis; Recombinant Proteins; Staphylococcus aureus; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1991 |
Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.
Topics: Animals; Aspirin; Complement Activation; Complement System Proteins; Dose-Response Relationship, Drug; Endotoxins; Female; Furans; Hypertension, Pulmonary; Hypoxia; Neutropenia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sheep; Thromboxanes; Zymosan | 1987 |
[Effect of corticosteroids, quinacrine and L-652, 731 on experimental aggregation of polymorphonuclear leukocytes induced by complement and platelet activating factor (PAF)].
Topics: Agranulocytosis; Animals; Cell Aggregation; Complement System Proteins; Furans; Methylprednisolone; Methylprednisolone Hemisuccinate; Neutropenia; Platelet Activating Factor; Quinacrine; Rabbits; Zymosan | 1988 |
Aberrant phagocyte function in Shwachman syndrome.
Topics: Agranulocytosis; Chemotaxis, Leukocyte; Child; Exocrine Pancreatic Insufficiency; Humans; Luminescent Measurements; Monocytes; Neutropenia; Neutrophils; Phagocytosis; Syndrome; Zymosan | 1987 |
Effects of verapamil on thromboxane synthesis and pulmonary hypertension in sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Complement Activation; Female; Hypertension, Pulmonary; Hypoxia; Neutropenia; Sheep; Thromboxane B2; Verapamil; Zymosan | 1986 |
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire.
Topics: Adolescent; Adult; Benzhydryl Compounds; Child; Child, Preschool; Glucosides; Glycogen Storage Disease Type I; Granulocyte Colony-Stimulating Factor; Humans; Infant; Infant, Newborn; Neutropenia; Retrospective Studies; Surveys and Questionnaires; Young Adult | 2022 |
Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5.
Topics: Animals; Antiporters; Benzhydryl Compounds; Glucose-6-Phosphatase; Glucosides; Glycogen Storage Disease Type I; Humans; Mice; Monosaccharide Transport Proteins; Mutation; Neutropenia; Phosphoric Monoester Hydrolases; Sodium-Glucose Transport Proteins | 2022 |
Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.
Topics: Benzhydryl Compounds; Blood Glucose; Chemotaxis, Leukocyte; Child, Preschool; Drug Repositioning; Drug Resistance; Female; Glucosides; Glycogen Storage Disease Type I; Granulocyte Colony-Stimulating Factor; Granulocytes; Hexosephosphates; Humans; Infant, Newborn; Lysosomal-Associated Membrane Protein 2; Male; Neutropenia; Neutrophils; Off-Label Use; Respiratory Burst; Sodium-Glucose Transporter 2 Inhibitors; Young Adult | 2020 |
Empagliflozin ameliorated neutropenia in a girl with glycogen storage disease Ib.
Topics: Benzhydryl Compounds; Female; Glucosides; Glycogen Storage Disease Type I; Humans; Neutropenia | 2021 |